|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 252.55 USD | +2.78% |
|
-7.02% | +4.85% |
| 11/02 | Resmed Insider Sold Shares Worth $1,366,436, According to a Recent SEC Filing | MT |
| 07/02 | Resmed Insider Sold Shares Worth $502,620, According to a Recent SEC Filing | MT |
| Capitalization | 36.79B 31B 28.28B 26.99B 50.11B 3,332B 52.06B 329B 131B 1,609B 138B 135B 5,624B | P/E ratio 2026 * |
23.9x | P/E ratio 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise value | 35.73B 30.1B 27.46B 26.21B 48.66B 3,236B 50.55B 319B 127B 1,563B 134B 131B 5,461B | EV / Sales 2026 * |
6.33x | EV / Sales 2027 * | 5.75x |
| Free-Float |
76.64% | Yield 2026 * |
0.96% | Yield 2027 * | 1.07% |
Last Transcript: ResMed, Inc.
| 1 day | +2.78% | ||
| 1 week | -7.02% | ||
| Current month | -2.23% | ||
| 1 month | -2.68% | ||
| 3 months | +3.31% | ||
| 6 months | -11.30% | ||
| Current year | +4.85% |
| 1 week | 245.65 |  | 277.67 |
| 1 month | 245.21 | | 277.67 |
| Current year | 240 | | 277.67 |
| 1 year | 199.92 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 55.13 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Brett Sandercock
DFI | Director of Finance/CFO | 59 | 01/01/2006 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.48% | 1.09% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.78% | -7.02% | +8.40% | +18.06% | 36.79B | |
| -0.98% | -7.00% | -5.08% | -11.66% | 190B | |
| +1.51% | -0.47% | -18.42% | +101.52% | 173B | |
| -1.10% | -1.86% | +3.04% | -17.04% | 150B | |
| +0.82% | -2.02% | -29.57% | +58.06% | 111B | |
| +0.79% | -1.74% | -29.86% | -20.76% | 53.87B | |
| -0.75% | -3.61% | -0.42% | -0.94% | 44.03B | |
| +2.15% | -0.38% | -12.87% | +10.65% | 36.61B | |
| +0.74% | -2.91% | -6.58% | -17.79% | 35.58B | |
| -1.19% | -1.96% | -25.99% | -42.05% | 32.52B | |
| Average | +0.48% | -2.48% | -11.74% | +7.80% | 86.27B | |
| Weighted average by Cap. | +0.21% | -2.46% | -11.40% | +19.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.64B 4.76B 4.34B 4.14B 7.69B 511B 7.99B 50.46B 20.03B 247B 21.17B 20.73B 863B | 6.07B 5.11B 4.66B 4.45B 8.27B 550B 8.59B 54.25B 21.53B 265B 22.76B 22.29B 928B |
| Net income | 1.55B 1.3B 1.19B 1.14B 2.11B 140B 2.19B 13.83B 5.49B 67.67B 5.8B 5.68B 237B | 1.73B 1.45B 1.33B 1.27B 2.35B 156B 2.44B 15.43B 6.12B 75.48B 6.47B 6.34B 264B |
| Net Debt | -1.07B -898M -819M -782M -1.45B -96.53B -1.51B -9.53B -3.78B -46.61B -4B -3.91B -163B | -1.87B -1.58B -1.44B -1.37B -2.55B -170B -2.65B -16.74B -6.65B -81.92B -7.02B -6.88B -286B |
Employees
10,600
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 252.55 $ | +2.78% | 970,998 |
| 12/02/26 | 245.73 $ | -5.35% | 1,567,468 |
| 11/02/26 | 259.62 $ | -1.49% | 1,179,113 |
| 10/02/26 | 263.54 $ | -4.50% | 1,811,950 |
| 09/02/26 | 275.96 $ | +1.59% | 1,479,277 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
252.55USD
Average target price
297.47USD
Spread / Average Target
+17.79%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition